| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 MYO1C CCT3 ERCC6L VWA8 MYO9A ABCA13 MCM6 BPTF DDX46 MYO3B ATP11A RFT1 DNAH6 DNAH9 DYNC1H1 KIFC1 DYNC2H1 ABCB5 CHD7 ORC4 | 2.42e-06 | 614 | 211 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 CCT3 ERCC6L VWA8 ABCA13 MCM6 DDX46 ATP11A DNAH6 DNAH9 DYNC1H1 KIFC1 DYNC2H1 ABCB5 CHD7 ORC4 | 1.97e-05 | 441 | 211 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.30e-05 | 18 | 211 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.68e-05 | 118 | 211 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 4.16e-05 | 37 | 211 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | bone sialoprotein binding | 1.11e-04 | 2 | 211 | 2 | GO:0044730 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide mannosidase activity | 1.32e-04 | 10 | 211 | 3 | GO:0015924 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.03e-04 | 28 | 211 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | alpha-mannosidase activity | 4.82e-04 | 15 | 211 | 3 | GO:0004559 | |
| GeneOntologyMolecularFunction | mannosidase activity | 5.88e-04 | 16 | 211 | 3 | GO:0015923 | |
| GeneOntologyMolecularFunction | floppase activity | 5.88e-04 | 16 | 211 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.71e-04 | 70 | 211 | 5 | GO:0003777 | |
| Domain | ATPase_dyneun-rel_AAA | 3.01e-07 | 14 | 208 | 5 | IPR011704 | |
| Domain | AAA_5 | 3.01e-07 | 14 | 208 | 5 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.37e-05 | 14 | 208 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.37e-05 | 14 | 208 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.37e-05 | 14 | 208 | 4 | IPR013602 | |
| Domain | DHC_N2 | 1.37e-05 | 14 | 208 | 4 | PF08393 | |
| Domain | MT | 1.37e-05 | 14 | 208 | 4 | PF12777 | |
| Domain | AAA_8 | 1.37e-05 | 14 | 208 | 4 | PF12780 | |
| Domain | DHC_fam | 1.85e-05 | 15 | 208 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 1.85e-05 | 15 | 208 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.85e-05 | 15 | 208 | 4 | IPR004273 | |
| Domain | AAA | 3.44e-05 | 144 | 208 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 3.44e-05 | 144 | 208 | 9 | IPR003593 | |
| Domain | DHC_N1 | 7.32e-05 | 8 | 208 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 7.32e-05 | 8 | 208 | 3 | IPR013594 | |
| Domain | Serine_rich | 3.68e-04 | 3 | 208 | 2 | IPR014928 | |
| Domain | Vitellinogen_superhlx | 3.68e-04 | 3 | 208 | 2 | IPR011030 | |
| Domain | VPS13 | 3.68e-04 | 3 | 208 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 3.68e-04 | 3 | 208 | 2 | PF16910 | |
| Domain | VPS13 | 3.68e-04 | 3 | 208 | 2 | PF16908 | |
| Domain | VPS13_N2 | 3.68e-04 | 3 | 208 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 3.68e-04 | 3 | 208 | 2 | IPR031642 | |
| Domain | Serine_rich | 3.68e-04 | 3 | 208 | 2 | PF08824 | |
| Domain | SHR-BD | 7.30e-04 | 4 | 208 | 2 | IPR009543 | |
| Domain | CAS_DUF3513 | 7.30e-04 | 4 | 208 | 2 | IPR021901 | |
| Domain | VPS13_C | 7.30e-04 | 4 | 208 | 2 | PF16909 | |
| Domain | VPS13_C | 7.30e-04 | 4 | 208 | 2 | IPR031645 | |
| Domain | DUF3513 | 7.30e-04 | 4 | 208 | 2 | PF12026 | |
| Domain | SHR-BD | 7.30e-04 | 4 | 208 | 2 | PF06650 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MAN2A2 MYCBP2 VWA8 OBSCN BIRC6 LYST RYR1 HIRA PCNX2 FAT1 MCM3AP WDR90 GCN1 DYNC1H1 WNK2 SZT2 FBXL14 LAMA5 TLNRD1 AATK COQ4 CTDP1 TANC1 WDFY3 SPATA13 | 2.68e-08 | 1105 | 215 | 25 | 35748872 |
| Pubmed | CAND1 CCT3 NEK9 ADSL RAB3GAP2 GCN1 SHMT2 COX15 CBR1 SH3GLB1 GTF3C1 XIRP2 TJP1 TBK1 TMPO | 1.11e-07 | 437 | 215 | 15 | 20562859 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CCT3 VPS13C OBSCN BIRC6 ERLEC1 RYR1 LRRC47 IGSF10 MYO3B MCM3AP TBC1D14 VPS13A DYNC1H1 IPPK CACNA1F MXRA5 GTF3C1 TBK1 TMPO | 1.91e-07 | 736 | 215 | 19 | 29676528 |
| Pubmed | CAND1 CCT3 BIRC6 GTF3C4 LRRC47 BPTF KCTD6 GCN1 VDR RC3H2 PLCD4 CHD7 CCDC141 MTA1 GTF3C1 | 2.73e-07 | 469 | 215 | 15 | 27634302 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UTP6 CAND1 MYO1C CCT3 MYCBP2 MYO9A MCM6 BIRC6 NEK9 GTF3C4 HIRA LRRC47 ADSL MCM3AP UQCRC2 GCN1 DYNC1H1 SHMT2 CHD7 CBR1 IGF2BP2 C5orf24 GTF3C1 TANC1 WDFY3 CDC20 | 3.37e-07 | 1353 | 215 | 26 | 29467282 |
| Pubmed | MAN2A2 MYCBP2 OBSCN BIRC6 NEK9 RYR1 NEDD9 VAV2 VWF CCDC141 SH3GLB1 AKAP9 XIRP2 TBK1 ANKRD1 | 5.68e-07 | 497 | 215 | 15 | 23414517 | |
| Pubmed | UTP6 MYO1C CCT3 MYCBP2 MCM6 BIRC6 LRRC47 BPTF DDX46 MCM3AP UQCRC2 GCN1 DYNC1H1 CHD7 IGF2BP2 GTF3C1 TJP1 | 7.70e-07 | 653 | 215 | 17 | 22586326 | |
| Pubmed | NMNAT2 CAND1 VWA8 VPS13C LRRC47 DDX46 SEMA5B WDR90 WNK2 ACAP3 PDPR SZT2 LAMA5 EDEM1 EXOSC7 | 1.23e-06 | 529 | 215 | 15 | 14621295 | |
| Pubmed | CAND1 MYO1C MYCBP2 VWA8 MCM6 GTF3C4 VPS13A LRRC41 SZT2 DYNC2H1 CIP2A SHMT2 COX15 TBK1 DNAJC11 TMPO | 1.37e-06 | 606 | 215 | 16 | 36538041 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MAGOH MYO1C CCT3 MYCBP2 VWA8 VPS13C BIRC6 SPTBN5 ADSL RAB3GAP2 CCDC138 VPS13A DNAJC1 UQCRC2 PDPR CIP2A SHMT2 COX15 IGF2BP2 CRYZ AKAP9 DNAJC11 TMPO TANC1 CDC20 GFM1 | 2.18e-06 | 1496 | 215 | 26 | 32877691 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | UTP6 KNTC1 CAND1 MYO1C CCT3 VPS13C MCM6 NEK9 LRRC47 ADSL RAB3GAP2 UQCRC2 GCN1 DYNC1H1 KIFC1 DYNC2H1 ANXA2 SHMT2 APOB CBR1 GTF3C1 TBK1 DNAJC11 TMPO GFM1 | 2.94e-06 | 1425 | 215 | 25 | 30948266 |
| Pubmed | 3.85e-06 | 195 | 215 | 9 | 19454010 | ||
| Pubmed | MAN2A2 VWA8 AVL9 GTF3C4 ITIH2 LRRC47 DDX46 MCM3AP UQCRC2 GCN1 DYNC1H1 TMED1 RC3H2 ANXA2 SHMT2 APOB CHD7 IGF2BP2 CRYZ AKAP9 TJP1 TBK1 TMPO CDC20 | 4.89e-06 | 1371 | 215 | 24 | 36244648 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 5.34e-06 | 203 | 215 | 9 | 22083510 | |
| Pubmed | MCM6 BIRC6 NEK9 LRRC47 ADSL RAB3GAP2 GCN1 DYNC1H1 ORC4 IGF2BP2 MTA1 GTF3C1 TMPO GFM1 | 6.88e-06 | 534 | 215 | 14 | 35032548 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 7.29e-06 | 211 | 215 | 9 | 17314511 | |
| Pubmed | Structure and chromosome assignment of the murine p36 (calpactin I heavy chain) gene. | 8.01e-06 | 7 | 215 | 3 | 2138915 | |
| Pubmed | MYO1C CCT3 MYCBP2 BIRC6 KIAA0753 CCDC138 VPS13A PPP1R9B UQCRC2 GCN1 PDPR CIP2A FBXL14 SHMT2 BCAR1 IGF2BP2 AKAP9 TJP1 TMPO TANC1 | 9.32e-06 | 1049 | 215 | 20 | 27880917 | |
| Pubmed | CAND1 CCT3 MYCBP2 NCAM1 NEK9 HIRA SLC12A5 PPP1R9B NOS1 DYNC1H1 WNK2 RAPGEF4 CHD7 AKAP9 TJP1 TBK1 WDFY3 UNC13A SPATA13 | 9.78e-06 | 963 | 215 | 19 | 28671696 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 9.83e-06 | 219 | 215 | 9 | 31353912 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ABCA13 CARMIL3 LYST RYR1 FAT1 VPS13A VWF SZT2 MUC16 CPZ CHD7 GUCY2C TJP1 TENM1 | 9.99e-06 | 552 | 215 | 14 | 10737800 |
| Pubmed | KNTC1 SPAG1 MYO1C CCT3 DZIP1L MMP21 LYST ERLEC1 BPTF VPS13A PPP1R9B ATP11A UQCRC2 DNAH6 ANXA2 ABCB5 APOB GTF3C1 TJP1 DNAJC11 TENM1 TMPO CCDC158 SPATA13 | 1.13e-05 | 1442 | 215 | 24 | 35575683 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CAND1 MYO1C CCT3 MYCBP2 MCM6 BIRC6 NEK9 GTF3C4 LRRC47 ADSL UQCRC2 GCN1 DYNC1H1 LRRC41 ANXA2 ANXA2P2 SHMT2 COX15 GTF3C1 DNAJC11 TMPO GFM1 | 1.25e-05 | 1257 | 215 | 22 | 37317656 |
| Pubmed | KNTC1 ERCC6L MYCBP2 VPS13C BIRC6 ERLEC1 GTF3C4 RAB3GAP2 DNAJC1 CIP2A MFSD9 CHD7 TJP1 TANC1 CDC20 GFM1 | 1.50e-05 | 733 | 215 | 16 | 34672954 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NEK9 NEDD9 WDR90 DYNC1H1 WNK2 CHD7 BCAR1 CCDC141 MTA1 AATK XIRP2 NBPF9 | 1.71e-05 | 430 | 215 | 12 | 35044719 |
| Pubmed | 1.73e-05 | 87 | 215 | 6 | 12465718 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CAND1 MAN1A1 MYO1C CCT3 VPS13C RYR1 FAT1 DYNC1H1 MXRA5 VWF DYNC2H1 ANXA2 GPT LAMA5 SHMT2 PKD1L3 CBR1 CRYZ CTH | 2.05e-05 | 1016 | 215 | 19 | 19056867 |
| Pubmed | ABCA1 VWA8 BIRC6 VPS13A TMEM65 PDPR SHMT2 COX15 CBR1 GTF3C1 TBK1 DNAJC11 GFM1 | 2.19e-05 | 515 | 215 | 13 | 31617661 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | UTP6 CAND1 CCT3 MYCBP2 MCM6 BPTF DDX46 UQCRC2 GCN1 DYNC1H1 KIFC1 ANXA2 SHMT2 CBR1 IGF2BP2 GTF3C1 TJP1 TBK1 TMPO | 2.28e-05 | 1024 | 215 | 19 | 24711643 |
| Pubmed | 2.32e-05 | 187 | 215 | 8 | 26460568 | ||
| Pubmed | 2.32e-05 | 244 | 215 | 9 | 28902428 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | UTP6 CAND1 MAN1A1 ERCC6L MCM6 ERLEC1 LRRC47 RAB3GAP2 RFT1 GCN1 DYNC1H1 DYNC2H1 CIP2A SPAG5 TBK1 DNAJC11 TMPO CTH | 2.57e-05 | 942 | 215 | 18 | 31073040 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERCC6L MYCBP2 MYO9A PAK6 LYST NEK9 KIAA0753 RAB3GAP2 CCDC138 STIL BCAR1 AKAP9 TJP1 OTUD7A TANC1 CDC20 SPATA13 | 2.89e-05 | 861 | 215 | 17 | 36931259 |
| Pubmed | CAND1 MYO1C CCT3 VPS13C NCAM1 BIRC6 FAT1 VPS13A GCN1 SDK1 DYNC1H1 MUC16 APOB AP4E1 TJP1 TMPO | 3.03e-05 | 777 | 215 | 16 | 35844135 | |
| Pubmed | CAND1 MYO9A PKD1L2 RAB3GAP2 FDXR DYNC1H1 DYNC2H1 ABCB5 AP4E1 CRYZ | 3.56e-05 | 322 | 215 | 10 | 26514267 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | UTP6 CCT3 MCM6 BIRC6 GTF3C4 LRRC47 RAB3GAP2 FDXR UQCRC2 GCN1 DYNC1H1 PDPR SHMT2 IGF2BP2 GTF3C1 | 3.66e-05 | 704 | 215 | 15 | 29955894 |
| Pubmed | Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate. | 3.80e-05 | 2 | 215 | 2 | 23148505 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 3013423 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 28694219 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 17549680 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 33164878 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 39384746 | ||
| Pubmed | Genetic analysis of the cytoplasmic dynein subunit families. | 3.80e-05 | 2 | 215 | 2 | 16440056 | |
| Pubmed | Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. | 3.80e-05 | 2 | 215 | 2 | 19841537 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 22589245 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 34392356 | ||
| Pubmed | Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. | 3.80e-05 | 2 | 215 | 2 | 22185818 | |
| Pubmed | A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. | 3.80e-05 | 2 | 215 | 2 | 21486955 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 19580511 | ||
| Pubmed | Oscillation of Cdc20-APC/C-mediated CAMDI stability is critical for cortical neuron migration. | 3.80e-05 | 2 | 215 | 2 | 34298015 | |
| Pubmed | Nuclear localization of human MEIOB requires its NLS in the OB domain and interaction with SPATA22. | 3.80e-05 | 2 | 215 | 2 | 36331299 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 36739096 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 22517898 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 30462534 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 25502651 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 21572519 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 37832154 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 30902828 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 32687500 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 39006851 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 24366262 | ||
| Pubmed | Agents that bind annexin A2 suppress ocular neovascularization. | 3.80e-05 | 2 | 215 | 2 | 20607799 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 31253864 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 19628708 | ||
| Pubmed | Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. | 3.80e-05 | 2 | 215 | 2 | 20847146 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 28453612 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 19536308 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 38290972 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 35064931 | ||
| Pubmed | Complex Roles of Annexin A2 in Host Blood-Brain Barrier Invasion by Cryptococcus neoformans. | 3.80e-05 | 2 | 215 | 2 | 28130864 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 20826156 | ||
| Pubmed | Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue. | 3.80e-05 | 2 | 215 | 2 | 27468426 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 27389701 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 17360942 | ||
| Pubmed | Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina. | 3.80e-05 | 2 | 215 | 2 | 19587120 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 19022301 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 38253182 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 27603575 | ||
| Pubmed | Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2. | 3.80e-05 | 2 | 215 | 2 | 21737841 | |
| Pubmed | Identification of gene markers for the prediction of allograft rejection or permanent acceptance. | 3.80e-05 | 2 | 215 | 2 | 17456197 | |
| Pubmed | Brain-specific transcript variants of 5' and 3' ends of mouse VPS13A and VPS13C. | 3.80e-05 | 2 | 215 | 2 | 17196930 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 30076206 | ||
| Pubmed | Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis. | 3.80e-05 | 2 | 215 | 2 | 38092984 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 21788340 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 27371724 | ||
| Pubmed | Identification of two novel polycystic kidney disease-1-like genes in human and mouse genomes. | 3.80e-05 | 2 | 215 | 2 | 12782129 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 31817350 | ||
| Pubmed | Cell surface translocation of annexin A2 facilitates glutamate-induced extracellular proteolysis. | 3.80e-05 | 2 | 215 | 2 | 24742684 | |
| Pubmed | Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris. | 3.80e-05 | 2 | 215 | 2 | 22453828 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 37967646 | ||
| Pubmed | Annexin A2 binds to the localization signal in the 3' untranslated region of c-myc mRNA. | 3.80e-05 | 2 | 215 | 2 | 15654879 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 4.05e-05 | 101 | 215 | 6 | 24613305 | |
| Pubmed | ERCC6L MYCBP2 NEK9 GTF3C4 BPTF DDX46 RAB3GAP2 GCN1 DYNC1H1 ANXA2 GTF3C1 TJP1 TMPO | 4.22e-05 | 549 | 215 | 13 | 38280479 | |
| Pubmed | USP11 deubiquitinates RAE1 and plays a key role in bipolar spindle formation. | 4.92e-05 | 12 | 215 | 3 | 29293652 | |
| Pubmed | 4.92e-05 | 12 | 215 | 3 | 19723394 | ||
| Pubmed | 6.02e-05 | 214 | 215 | 8 | 22199357 | ||
| Pubmed | MYCBP2 BIRC6 NEK9 GTF3C4 RAB3GAP2 GCN1 CIP2A CHD7 SPAG5 GTF3C1 TBK1 | 6.52e-05 | 418 | 215 | 11 | 34709266 | |
| Pubmed | 8.06e-05 | 14 | 215 | 3 | 9373155 | ||
| Pubmed | Enhancer interaction networks as a means for singular olfactory receptor expression. | 8.06e-05 | 14 | 215 | 3 | 25417106 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | CAND1 ERCC6L MCM6 GTF3C4 RAB3GAP2 PPP1R9B SPATA22 DYNC1H1 ANAPC4 LRRC41 DYNC2H1 GTF3C1 TMPO CDC20 | 8.19e-05 | 670 | 215 | 14 | 22990118 |
| Interaction | EED interactions | UTP6 KNTC1 MAGOH CAND1 MAN1A1 MYO1C CCT3 MYCBP2 VPS13C OBSCN MCM6 BIRC6 NEK9 GTF3C4 BPTF RAB3GAP2 PPP1R9B UQCRC2 DYNC1H1 NID2 SZT2 CIP2A LAMA5 COX15 CHD7 CBR1 IGF2BP2 MTA1 GTF3C1 XIRP2 TJP1 UNC45B TBK1 TMPO PRKN TANC1 | 4.83e-07 | 1445 | 205 | 36 | int:EED |
| Cytoband | 16p12 | 3.55e-05 | 14 | 215 | 3 | 16p12 | |
| GeneFamily | Cas scaffolding proteins | 3.29e-04 | 4 | 135 | 2 | 469 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 OBSCN PKD1L2 FAT1 DNAH9 SDK1 CACNA1F APOB XIRP2 TENM1 CNTNAP4 | 1.69e-09 | 184 | 215 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 OBSCN PKD1L2 FAT1 DNAH9 SDK1 CACNA1F APOB XIRP2 TENM1 CNTNAP4 | 1.69e-09 | 184 | 215 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 OBSCN PKD1L2 FAT1 DNAH9 SDK1 CACNA1F APOB XIRP2 TENM1 CNTNAP4 | 1.69e-09 | 184 | 215 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPAG1 ABCA13 DZIP1L EFHB WDR90 DNAH6 DNAH9 DYNC2H1 TOGARAM2 MUC16 RFX3 | 2.94e-09 | 194 | 215 | 11 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 MYCBP2 CARMIL3 VPS13C VPS13A DYNC1H1 VDR DYNC2H1 RAPGEF4 AKAP9 SEZ6L | 3.10e-09 | 195 | 215 | 11 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 MYCBP2 CARMIL3 VPS13C VPS13A DYNC1H1 VDR DYNC2H1 RAPGEF4 AKAP9 SEZ6L | 3.10e-09 | 195 | 215 | 11 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ABCA13 DZIP1L EFHB DNAH6 DNAH9 WHRN DYNC2H1 TOGARAM2 MUC16 RFX3 | 1.04e-08 | 169 | 215 | 10 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPAG1 ABCA13 DZIP1L EFHB DNAH6 DNAH9 DYNC2H1 MUC16 RFX3 AKAP9 | 4.45e-08 | 197 | 215 | 10 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPAG1 ABCA13 DZIP1L EFHB DNAH6 DNAH9 DYNC2H1 MUC16 RFX3 AKAP9 | 4.45e-08 | 197 | 215 | 10 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPAG1 ABCA13 DZIP1L EFHB DNAH6 DNAH9 DYNC2H1 MUC16 RFX3 AKAP9 | 4.45e-08 | 197 | 215 | 10 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.54e-07 | 181 | 215 | 9 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.54e-07 | 181 | 215 | 9 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-07 | 189 | 215 | 9 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-07 | 189 | 215 | 9 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.65e-07 | 189 | 215 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.36e-07 | 193 | 215 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.55e-07 | 194 | 215 | 9 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | medial-2-Hematologic-IGSF21+_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | SLC12A5 FMN1 TBC1D14 SLC37A2 MS4A6A VDR CYSLTR2 OLFML2B PKD1L3 | 4.75e-07 | 195 | 215 | 9 | bb612979360b2322289545dda3d3c343d005ee6f |
| ToppCell | medial-Hematologic-IGSF21+_Dendritic-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | SLC12A5 FMN1 TBC1D14 SLC37A2 MS4A6A VDR CYSLTR2 OLFML2B PKD1L3 | 4.75e-07 | 195 | 215 | 9 | 779130c2cfcbc603955b0c0332b855b22ab6e9e6 |
| ToppCell | medial-Hematologic-IGSF21+_Dendritic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | SLC12A5 FMN1 TBC1D14 SLC37A2 MS4A6A VDR CYSLTR2 OLFML2B PKD1L3 | 4.75e-07 | 195 | 215 | 9 | 330b688d703d53cb7feb29373b5a6e6e529169ec |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.17e-07 | 197 | 215 | 9 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DZIP1L WDR90 DNAH6 DNAH9 DYNC2H1 TOGARAM2 RFX3 IGF2BP2 AKAP9 | 5.17e-07 | 197 | 215 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.63e-07 | 199 | 215 | 9 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.87e-07 | 200 | 215 | 9 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.87e-07 | 200 | 215 | 9 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.87e-07 | 200 | 215 | 9 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.87e-07 | 200 | 215 | 9 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.87e-07 | 200 | 215 | 9 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-06 | 172 | 215 | 8 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 123 | 215 | 7 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage-C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.49e-06 | 80 | 215 | 6 | 3413ac5e1c1e59eab6a83b889b870a8db4efccb9 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-06 | 179 | 215 | 8 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.38e-06 | 185 | 215 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 3.38e-06 | 185 | 215 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.52e-06 | 186 | 215 | 8 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-06 | 187 | 215 | 8 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.80e-06 | 188 | 215 | 8 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 3.80e-06 | 188 | 215 | 8 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.11e-06 | 190 | 215 | 8 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.11e-06 | 190 | 215 | 8 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.11e-06 | 190 | 215 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.28e-06 | 191 | 215 | 8 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l12-14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.44e-06 | 192 | 215 | 8 | 52d0aa51e3b6ab3608a5f40bdde9f8134b3afd94 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 4.44e-06 | 192 | 215 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.62e-06 | 193 | 215 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.62e-06 | 193 | 215 | 8 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 4.80e-06 | 194 | 215 | 8 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.80e-06 | 194 | 215 | 8 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.98e-06 | 195 | 215 | 8 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.98e-06 | 195 | 215 | 8 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.98e-06 | 195 | 215 | 8 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-06 | 195 | 215 | 8 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.17e-06 | 196 | 215 | 8 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.37e-06 | 197 | 215 | 8 | 7eb4c1cffd0366204af7e63adc8f751685601a94 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.37e-06 | 197 | 215 | 8 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.57e-06 | 198 | 215 | 8 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.57e-06 | 198 | 215 | 8 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.57e-06 | 198 | 215 | 8 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.57e-06 | 198 | 215 | 8 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 5.78e-06 | 199 | 215 | 8 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.78e-06 | 199 | 215 | 8 | 6748d4f76703360071d5f2026d9d06bf30ccfb6d | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 5.78e-06 | 199 | 215 | 8 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.78e-06 | 199 | 215 | 8 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.78e-06 | 199 | 215 | 8 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | TCGA-Lung-Primary_Tumor|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.78e-06 | 199 | 215 | 8 | d1d035e987280607266171094db5d6362efe1ad5 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.78e-06 | 199 | 215 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.78e-06 | 199 | 215 | 8 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.00e-06 | 200 | 215 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 6.00e-06 | 200 | 215 | 8 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 6.00e-06 | 200 | 215 | 8 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.00e-06 | 200 | 215 | 8 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 6.00e-06 | 200 | 215 | 8 | 9769185abae084ffac36420c749625e679b70ca8 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.00e-06 | 200 | 215 | 8 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.00e-06 | 200 | 215 | 8 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 6.00e-06 | 200 | 215 | 8 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|COVID-19 / Condition, Lineage and Cell class | 6.00e-06 | 200 | 215 | 8 | b239c711cce967826432fdbd5f88eba98a88bb0c | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.51e-06 | 144 | 215 | 7 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-05 | 163 | 215 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 165 | 215 | 7 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 168 | 215 | 7 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | (05)_Ciliated-(3)_72hpi|(05)_Ciliated / shred by cell type and Timepoint | 1.83e-05 | 113 | 215 | 6 | eaa5bc8f8183b353ee1e7618e99220eb3684cd60 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-05 | 169 | 215 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.92e-05 | 170 | 215 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.92e-05 | 170 | 215 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.92e-05 | 170 | 215 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 171 | 215 | 7 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 173 | 215 | 7 | 20a20429aa898097d5ec4880ed64846558b5890f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-05 | 174 | 215 | 7 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.31e-05 | 175 | 215 | 7 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 176 | 215 | 7 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 177 | 215 | 7 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 177 | 215 | 7 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 179 | 215 | 7 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | Ciliated_cells-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.67e-05 | 179 | 215 | 7 | 1c41314b6fcfcac8d62034e7037570120d58f20f | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-05 | 180 | 215 | 7 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-05 | 180 | 215 | 7 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 2.77e-05 | 180 | 215 | 7 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.77e-05 | 180 | 215 | 7 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.87e-05 | 181 | 215 | 7 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.87e-05 | 181 | 215 | 7 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| Disease | Colorectal Carcinoma | ABCA1 ABCA13 SLC22A15 OBSCN PAK6 SLC12A5 LRRC47 FAT1 GDAP1L1 MCM3AP VPS13A SCNN1G UQCRC2 ANAPC4 ABCB5 APOB TLR9 AKAP9 GUCY2C TENM1 | 1.58e-07 | 702 | 209 | 20 | C0009402 |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 4.99e-05 | 2 | 209 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 4.99e-05 | 2 | 209 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | X-11795 measurement | 1.49e-04 | 3 | 209 | 2 | EFO_0021261 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 1.49e-04 | 3 | 209 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 1.49e-04 | 3 | 209 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 2.97e-04 | 4 | 209 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | Polyneuropathy | 2.97e-04 | 4 | 209 | 2 | C0152025 | |
| Disease | aortic valve stenosis (is_implicated_in) | 4.92e-04 | 5 | 209 | 2 | DOID:1712 (is_implicated_in) | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 7.35e-04 | 6 | 209 | 2 | DOID:13809 (is_marker_for) | |
| Disease | non-alcoholic fatty liver disease (is_marker_for) | 9.04e-04 | 27 | 209 | 3 | DOID:0080208 (is_marker_for) | |
| Disease | LDL cholesterol change measurement | 1.02e-03 | 7 | 209 | 2 | EFO_0007804 | |
| Disease | asphyxiating thoracic dystrophy (is_implicated_in) | 1.02e-03 | 7 | 209 | 2 | DOID:0050592 (is_implicated_in) | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.32e-03 | 67 | 209 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | glucagon-like peptide-1 measurement, glucose tolerance test | 1.36e-03 | 8 | 209 | 2 | EFO_0004307, EFO_0008465 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.36e-03 | 8 | 209 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | fear of minor pain measurement | 1.36e-03 | 31 | 209 | 3 | EFO_0008340 | |
| Disease | uric acid measurement | ABCA1 REG4 MYO9A BIRC6 FMN1 RFT1 ANAPC4 IPPK DYNC2H1 ORC4 IGF2BP2 TANC1 | 1.45e-03 | 610 | 209 | 12 | EFO_0004761 |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.74e-03 | 9 | 209 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Spastic Paraplegia | 1.74e-03 | 9 | 209 | 2 | C0037772 | |
| Disease | Situs ambiguous | 1.74e-03 | 9 | 209 | 2 | C1167664 | |
| Disease | Parkinson's disease (is_implicated_in) | 2.11e-03 | 76 | 209 | 4 | DOID:14330 (is_implicated_in) | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 2.28e-03 | 37 | 209 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Situs Inversus | 2.63e-03 | 11 | 209 | 2 | C0037221 | |
| Disease | attention deficit hyperactivity disorder, conduct disorder | 2.85e-03 | 40 | 209 | 3 | EFO_0003888, EFO_0004216 | |
| Disease | peptic esophagitis (biomarker_via_orthology) | 3.14e-03 | 12 | 209 | 2 | DOID:13976 (biomarker_via_orthology) | |
| Disease | middle cerebral artery infarction (is_implicated_in) | 3.14e-03 | 12 | 209 | 2 | DOID:3525 (is_implicated_in) | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 3.14e-03 | 12 | 209 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | response to ketamine, dissociation measurement | 3.70e-03 | 13 | 209 | 2 | EFO_0009748, EFO_0009750 | |
| Disease | Hyperlipoproteinemia Type IIb | 3.70e-03 | 13 | 209 | 2 | C1704417 | |
| Disease | left ventricular systolic function measurement | 3.75e-03 | 44 | 209 | 3 | EFO_0008206 | |
| Disease | schizophrenia (is_marker_for) | 3.75e-03 | 44 | 209 | 3 | DOID:5419 (is_marker_for) | |
| Disease | body weight | KNTC1 MAN1A1 VPS13C PAK6 ERLEC1 BPTF ADSL ANAPC4 IPPK NID2 CHD7 RFX3 KCNRG LHCGR IGF2BP2 AATK FEZ2 CNTNAP4 | 3.91e-03 | 1261 | 209 | 18 | EFO_0004338 |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 4.25e-03 | 46 | 209 | 3 | EFO_0005325, HP_0012735 | |
| Disease | triacylglycerol 54:4 measurement | 4.25e-03 | 46 | 209 | 3 | EFO_0010422 | |
| Disease | Malignant neoplasm of breast | OBSCN SEMA5B SMOX DNAH9 VDR TMED1 NID2 VWF DYNC2H1 MFSD9 FAM131A BCAR1 LHCGR AKAP9 UNC45B TENM1 | 4.29e-03 | 1074 | 209 | 16 | C0006142 |
| Disease | respiratory quotient | 4.30e-03 | 14 | 209 | 2 | EFO_0005189 | |
| Disease | T wave morphology measurement | 4.30e-03 | 14 | 209 | 2 | EFO_0008398 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 4.30e-03 | 14 | 209 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | Kidney Failure, Chronic | 4.79e-03 | 48 | 209 | 3 | C0022661 | |
| Disease | Situs ambiguus | 4.93e-03 | 15 | 209 | 2 | C0266642 | |
| Disease | hepcidin:transferrin saturation ratio | 4.93e-03 | 15 | 209 | 2 | EFO_0007902 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 5.08e-03 | 49 | 209 | 3 | EFO_0021897 | |
| Disease | asthma (is_implicated_in) | 5.31e-03 | 157 | 209 | 5 | DOID:2841 (is_implicated_in) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 5.31e-03 | 157 | 209 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | diabetic retinopathy (is_implicated_in) | 5.37e-03 | 50 | 209 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | Hyperlipoproteinemia Type IIa | 5.61e-03 | 16 | 209 | 2 | C0745103 | |
| Disease | focal segmental glomerulosclerosis | 5.61e-03 | 16 | 209 | 2 | EFO_0004236 | |
| Disease | Cannabis use | 5.61e-03 | 16 | 209 | 2 | EFO_0007585 | |
| Disease | Uremia | 6.33e-03 | 17 | 209 | 2 | C0041948 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 6.33e-03 | 17 | 209 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Fetal Alcohol Syndrome | 6.33e-03 | 17 | 209 | 2 | C0015923 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RVSDVTKAGHSLELI | 296 | P11473 | |
| KSAVSGAIRLHISVE | 791 | Q9UPW8 | |
| TVLKLLVAGEGHTRT | 166 | P24298 | |
| ATHLIAARAGTEKVL | 681 | Q9Y5B0 | |
| VGTTHISKLTDDQLI | 321 | Q96DZ1 | |
| RHVLGILDRSSKSQS | 1751 | Q99996 | |
| ATKLHISLSLERLSV | 391 | P59826 | |
| VAELKGHTSRVLSLT | 436 | Q12834 | |
| KLVISHLQSGSESLL | 346 | Q9UJX5 | |
| REKTSDISTLGHLVI | 891 | Q9NR09 | |
| LSAHKLVFIGDTLTR | 751 | Q14511 | |
| ILSAHKLVFIGDTLS | 786 | P56945 | |
| LRAITSTLADVKHTF | 1961 | Q8IZF6 | |
| DKLLSTALHVAVRTG | 216 | Q15327 | |
| SKGRTTIVVAHRLST | 571 | Q2M3G0 | |
| HLERTDITKAALGVL | 201 | P22570 | |
| ATHLSSLGTLKVRVL | 236 | Q6UY09 | |
| AQKEHSILLSISSLG | 91 | A0A1B0GTL2 | |
| EATKTLLHSLGTLAQ | 256 | O95477 | |
| LAATVTITHLLKAGD | 91 | P32929 | |
| VTKIVITDTGRLHSE | 761 | Q9C0A0 | |
| SAVKSLVLGRILEHS | 1136 | Q9C0A0 | |
| RGSSLTFLTQISKHI | 981 | Q86UQ4 | |
| TLLHGITISNITKED | 1776 | Q86UQ4 | |
| TLAIVLKTSGIFAHS | 3631 | Q86UQ4 | |
| RSLGVHCSKVRSLTL | 446 | Q96P50 | |
| ALKSALSGHLETVIL | 86 | P07355 | |
| HGSKVLTISTLRLTI | 896 | Q12830 | |
| ALKSALSGHLETVIL | 86 | A6NMY6 | |
| LLRRTHTITIESEGK | 1491 | Q9P2D1 | |
| IAHELGRSVTDVTTK | 356 | Q96KC8 | |
| LGSLVRGITALTSKH | 36 | Q9UPM8 | |
| ITTSVSAGNLILKTH | 1156 | Q9HBD1 | |
| HLLRLTSSLTTKGAS | 81 | P22695 | |
| SKDLSLLSHGGRVIV | 231 | Q08257 | |
| ATLGTAFLTETKLIH | 511 | Q96AA3 | |
| SEGITSLHRKVEIIT | 1151 | Q68DA7 | |
| RIHVSGSTIAILKRT | 961 | P25092 | |
| LVHVITRVLLSGSDK | 261 | Q9H8X2 | |
| FRKVLGDIHTTLLSA | 311 | Q96MZ0 | |
| ADIVTTTTHKTLRGA | 271 | P34897 | |
| ASEVDSLGVILKVTH | 751 | Q17RG1 | |
| AKGISIQTLRHLESL | 476 | Q8IYY4 | |
| TFVLSHRARSGLKIS | 406 | Q8N635 | |
| LKRTALHGESNSVLI | 51 | O43929 | |
| LLSHVALAVASKLTS | 326 | Q9H2M9 | |
| GIHSSAISVVKILRV | 956 | O60840 | |
| KLSIRATDSLTGAHA | 2251 | Q14517 | |
| AVLHKLTTGATETSR | 6676 | Q8WXI7 | |
| GTLFLHKIVLGIETS | 31 | Q9H4B0 | |
| RKISRHSVLGAAVSV | 341 | Q9NVH1 | |
| HKIRELTSSRIGLLT | 121 | Q14566 | |
| HILATILSKASSSGR | 221 | Q8NGE0 | |
| GVIHRDIKSDSILLT | 521 | Q9NQU5 | |
| HVVLLLSRSKSTRGE | 36 | Q92813 | |
| LCLKVGISSRHLTAI | 206 | Q14667 | |
| GTTLTSLELKENVHL | 196 | P22888 | |
| HTVLITSRGAQILTK | 316 | Q6UB28 | |
| LIIDNKRSISHLSSG | 81 | Q8NCT3 | |
| AKTVVSHSLTTLGLE | 461 | P42166 | |
| KTHTAAIDERGRLLT | 606 | Q8TD19 | |
| VVGGLSHSSISRLKE | 246 | Q7LDG7 | |
| IKIEISTETITLSHG | 771 | P19823 | |
| KHTLSISRALLSDVV | 146 | Q8NBP5 | |
| RTFHLTRTLTVKVVG | 221 | Q9NPH3 | |
| TAATLATHELRAVKG | 371 | Q8N1G4 | |
| ETLGLIHTATKGLIR | 201 | Q8NCR3 | |
| HISFTTSKIGSLIDV | 96 | P61326 | |
| TTGILRHIAAEEVSK | 1126 | O60318 | |
| VLEQVLHTLSKSGSL | 231 | Q8ND23 | |
| LHTLSKSGSLEELVL | 236 | Q8ND23 | |
| LGTERTTLEGHLAKV | 181 | Q9BW19 | |
| HSLKEIISSASVVGL | 911 | Q86VP6 | |
| ESSLHLRVVGTEKTS | 391 | A6NKB5 | |
| GLKTLEHVAVTVSIT | 521 | Q16549 | |
| SDTGISLLKVAVHEI | 271 | Q8N119 | |
| SILTHDVIRKTGIAV | 136 | Q8NH63 | |
| HSVVSEFILLGLSKS | 6 | Q8NH42 | |
| AGILSTARHLTIEQK | 86 | Q8NCN5 | |
| TKVTLGRLHFSETTA | 336 | Q96LU7 | |
| TTGKLHVSLTRLTDG | 116 | Q8N8W4 | |
| TSTKDLVISLSGILH | 1506 | P50748 | |
| SRLKALGTLVSHVTL | 911 | Q92616 | |
| DTLLKEGFHLVSTRT | 216 | Q8N5I3 | |
| AIRAIETLSGKVELH | 51 | Q9Y6M1 | |
| EKRLSRGISHASSAI | 111 | Q8TE49 | |
| KTILISAHGNSSRAL | 181 | P07738 | |
| VLDAGHSVSTLEKTL | 2676 | O15230 | |
| IVTSILHIKSTQGRS | 221 | Q8NGG8 | |
| SGSARVKLGHTDILV | 46 | Q15024 | |
| TDLSLKHISRGLTGL | 216 | Q8N1E6 | |
| KVREHVLGSLSAVTT | 926 | Q7Z442 | |
| VLTDTLHLKSTLETG | 316 | P29475 | |
| HVLTLRQLALKDSGT | 3061 | Q5VST9 | |
| LGAHVTITDRKVALE | 86 | Q8WXB1 | |
| DAAKTLLSLHGSIIV | 1131 | Q14112 | |
| ALITTAVSADLGTHK | 406 | Q8TED4 | |
| HQSLAALSKVIRGTT | 4091 | Q8NCM8 | |
| EHTGLTLREVSSKLR | 4091 | P04114 | |
| LIHTSLETLNKAIAG | 3911 | Q9C0G6 | |
| RTKEITVHSGSTVEL | 1751 | Q6WRI0 | |
| TSALVKETLALLSTH | 26 | P05113 | |
| SVSRSSIDFLLTHKG | 161 | Q6E213 | |
| TELTEATGKLIRTSH | 876 | Q9BX69 | |
| HLRISSKGLLSNVID | 541 | Q96M89 | |
| HRLALSLGVDIISSV | 841 | Q6ZP82 | |
| ARISVKGIRHDITTA | 521 | Q66K79 | |
| KIHLSATRLVRVSTS | 296 | Q8N0S6 | |
| ETHLQTTSGRSIEIK | 61 | Q7Z6I8 | |
| TADVSHTNLGTIRKV | 266 | Q8NBF6 | |
| AVLGETTGHRTLKVL | 71 | Q9Y3A0 | |
| ALARSSLHGISQVVK | 101 | Q6UXB0 | |
| HVDKAVSGLRSLTTL | 121 | P01588 | |
| VSRHALLESSLKATR | 466 | O15033 | |
| VTKIGVTVLSRIHAR | 196 | P16152 | |
| LGSLLSAHRIITDSK | 231 | Q92611 | |
| GIRSHSLKAFETLII | 811 | Q99698 | |
| KLLVHSSLVGSILSA | 111 | Q9H2W1 | |
| KRLTLHTAQALGVSS | 936 | P49641 | |
| VQAIETHLIRKSSSG | 441 | P33908 | |
| LTHGIRSKISVLANT | 321 | Q8N7U6 | |
| LKGVTDHTQRLSIIT | 3846 | Q14204 | |
| TQLTITTKVHSLLEG | 141 | Q8NC69 | |
| LEKISRALGILTSHQ | 401 | Q9UKA1 | |
| SHLAKSGTSVILLDR | 51 | A6NKP2 | |
| TERLENGLLKLHSTS | 3066 | Q9NYC9 | |
| STLHFRSLGSAISKI | 211 | Q5M9N0 | |
| HRILGITSVTAITVL | 326 | Q7KZN9 | |
| VVVKEESLHSILAGS | 806 | P54198 | |
| TSVAARGLDVKHLIL | 676 | Q7L014 | |
| IIGSVITSATSVIHK | 466 | Q9BRP7 | |
| ISAHIDSGKTTLTER | 51 | Q96RP9 | |
| AVVNSHSLSLLGKLT | 396 | Q8IZD6 | |
| GHLSFTEILDTSLKV | 976 | Q7Z5N4 | |
| LVSSTGAKVIIHRQD | 321 | P51170 | |
| VKTLRTILSSVTHNG | 4821 | P21817 | |
| FKTLRIDGTVTHLLE | 501 | Q2NKX8 | |
| TRTLHLLTLNLSEKG | 111 | Q9UHY8 | |
| SDIHSAVLSTIRKLE | 576 | P46019 | |
| GVTSLSKELQRHVTV | 191 | A6NK58 | |
| IAAKSLGHTLVTVSV | 621 | Q5VU65 | |
| IVTSILHIKSTQGRS | 221 | Q96RD0 | |
| KTSTLKHLLGETRSD | 26 | Q96KF2 | |
| HLASILSLKEASTIA | 66 | Q9BYZ8 | |
| TTAGHLALLVTKNVS | 821 | Q9H2X9 | |
| LRLASAGKHRSEISV | 186 | Q8NGE3 | |
| IISSILKIHSSEGRS | 221 | Q8NGT0 | |
| VFLDSHLGKTSLTVV | 3376 | Q5T011 | |
| SIIKGAEFHVSLLSI | 231 | Q9NYH9 | |
| TLHRSISTKVLLAEG | 401 | Q6ZRF8 | |
| ALSHLSTTVKRELAG | 356 | Q8WZA2 | |
| VKFTLHTRDLLSTVL | 111 | Q8N3R3 | |
| KTTSHTELVRGARIT | 756 | Q9BYH1 | |
| KSGELISLREEVTHL | 1061 | Q96R06 | |
| GHTLTSRILFKDVVA | 351 | Q9BRC7 | |
| SVGLAVILHTDSRKD | 116 | O60260 | |
| HLGKVELASVTLAVA | 61 | Q86VL8 | |
| ETELLRQTHSSKISG | 171 | Q8NHS9 | |
| VTGEVTNLRSKVSHL | 536 | Q6ZUX3 | |
| RVLETLASSLHTLKF | 186 | Q15345 | |
| SVQLLKSTDVGRHSL | 111 | Q6ZMQ8 | |
| IDGKSHLILSSRSQV | 381 | Q8N0V4 | |
| KVDSTLIGSSSHVER | 506 | P0DPF3 | |
| LQKSDGLSTHRSSLL | 166 | P48380 | |
| VLSVLASLGASVHKI | 251 | P30566 | |
| LVKLLSSLVSSHLEG | 1036 | Q7Z443 | |
| AEITRLLLEGISSTH | 206 | Q9Y371 | |
| ATLIGKVSSHLVLRS | 686 | Q9C0D5 | |
| GASTIRLLTSLRAKH | 456 | P49368 | |
| LLSIDFDHITRTGKI | 1796 | Q9UKZ4 | |
| ELSRLISAHSSLSKG | 3521 | O75592 | |
| LKSSRHLILTVKDVG | 346 | Q9P202 | |
| AVTHAKILGSETLAT | 751 | Q2KHM9 | |
| ISSTLIALADKHATL | 51 | Q13330 | |
| LHSVTTKLVGRVDKL | 166 | Q68BL8 | |
| KHTFSLRLTSGAEIL | 3606 | Q9NRC6 | |
| RTLITLLAHSSLTVV | 191 | Q8TCG1 | |
| TSHKGILLETELALT | 31 | Q96DZ9 | |
| SGLRVSHRKALTTII | 236 | Q9NS75 | |
| VLFELSKTVLRHSGS | 726 | P98196 | |
| SKTVLRHSGSLTRDN | 731 | P98196 | |
| VRSHARVSSLTLKSI | 371 | P13591 | |
| DRSSELIHSGELTKI | 451 | Q96N96 | |
| TNVTLSSIKETRGLH | 201 | Q9P2M4 | |
| GDVKRTIHNLLSSTS | 1536 | A4UGR9 | |
| ASILSSILDTIFHKV | 156 | P46094 | |
| AVEALIHASTKLSRA | 441 | Q8IWX7 | |
| IHASTKLSRATFIIT | 446 | Q8IWX7 | |
| THGRILKNVSELIIS | 136 | Q8N184 | |
| GKLLSLRVHITSRES | 166 | Q15468 | |
| TSTRLISGHRSKVNE | 1426 | Q96KV7 | |
| RHTGESLTTKLNVTR | 766 | Q08AN1 | |
| LHLSVSLSSGREEAK | 2776 | Q96RL7 | |
| GKVCSRVSSLTLHLR | 61 | Q3ZCT1 | |
| TVTLKQALLGHTDTV | 3116 | Q8IZQ1 | |
| LKGDLRIQHTVTASV | 476 | P04275 | |
| LVSIRRQSKGHLTDS | 166 | Q86YL5 | |
| GTIHSIALTSLTIKL | 156 | P0C645 | |
| SHLSRLEGLVLKDSS | 281 | Q9NR96 | |
| ITIKDVVHITFLRGS | 286 | Q8NE28 | |
| HRSVSGLKQTLLAES | 271 | Q7Z404 | |
| SHLSKIETRIDTAGL | 186 | Q07617 | |
| TEKVAAIHRLGIGTT | 351 | Q9NWM0 | |
| TIIARTKGLSILTHD | 81 | Q9H1K6 | |
| TGLTHIIETRKVLDL | 676 | Q709C8 | |
| GTILKALSTASRSLH | 496 | Q9P283 | |
| IKLSDVFGSVRTHGI | 466 | Q9UKN8 | |
| TDQRSSGIIRLHTIK | 681 | Q07157 | |
| TRLSTHLGKAVGVTI | 201 | Q6PI78 | |
| LLVSESRKADGVHTV | 81 | Q13445 | |
| GKVISAVSRLSLHSI | 106 | P52735 | |
| VRQLKVVASSTGHLA | 2001 | Q9Y3S1 | |
| TGLGIISVISHLTKR | 221 | P0DMS9 | |
| LSTRTNHIETLGKLR | 266 | Q12789 | |
| TVLDVLEGRTHTISL | 1251 | A3KMH1 | |
| GEISDIHTKLLRLSS | 496 | Q9UHD2 | |
| IHTKLLRLSSSQGTI | 501 | Q9UHD2 | |
| DARTTALLLSVSHLV | 156 | Q9Y2Y6 | |
| LSGIRKVITESTVHL | 91 | Q309B1 | |
| LLSVEGSTLREALTH | 341 | O00159 | |
| GLTDNIHLVKSSLST | 1036 | Q9NR99 | |
| NKHSVSGTDLLSSRI | 1211 | Q8WXR4 | |
| NSTSSKLLERAHGIL | 826 | B2RTY4 | |
| DHSALLKLGTSVSER | 106 | Q96SB3 | |
| SVVSSTKSRLALQHG | 266 | Q9BZQ4 |